孢子丝菌病研究进展

doi:10.35541/cjd.20200415

中华皮肤科杂志 ›› 2022, Vol. 55 ›› Issue (7): 629-632.doi: 10.35541/cjd.20200415

孢子丝菌病研究进展

吕莎¹ 王爽¹ 武寒飞² 张明瑞¹ 胡馨¹ 李福秋¹

¹吉林大学第二医院皮肤科，长春 130041；²吉林省中医药科学院第一临床医院普通外科，长春 130000

收稿日期:2020-04-28 修回日期:2020-09-21 发布日期:2022-07-05
通讯作者: 李福秋 E-mail:lifuqiu1234@126.com
基金资助:
吉林省省级产业创新专项资金项目

Research progress in sporotrichosis

Lyu Sha¹, Wang Shuang¹, Wu Hanfei², Zhang Mingrui¹, Hu Xin¹, Li Fuqiu¹

¹Department of Dermatology, The Second Hospital of Jilin University, Changchun 130041, China; ²Department of General Surgery, The First Clinical Hospital of Academy of Science of TCM in Jilin Province, Changchun 130000, China

Received:2020-04-28 Revised:2020-09-21 Published:2022-07-05
Supported by:
Jilin Provincial Industrial Innovation Special Fund

摘要/Abstract

摘要： 【摘要】世界卫生组织将孢子丝菌病归为“被忽视的热带病”，近年来对孢子丝菌病相关的研究逐渐增多，本文从病原体、流行病学、诊断、治疗、疫苗这五个方面综述孢子丝菌病的近期研究进展。

关键词: 孢子丝菌病, 孢子丝菌属, 流行病学, 诊断, 治疗, 疫苗

Abstract: 【Abstract】 Sporotrichosis has been classified as “neglected tropical diseases” by the World Health Organization. In recent years, researches on sporotrichosis have gradually increased. This review summarizes recent progress in sporotrichosis in terms of pathogens, epidemiology, diagnosis, treatment and vaccines.

Key words: Sporotrichosis, Sporothrix, Epidemiology, Diagnosis, Treatment, Vaccine

中图分类号:

R756.6

吕莎王爽武寒飞张明瑞胡馨李福秋. 孢子丝菌病研究进展[J]. 中华皮肤科杂志, 2022,55(7):629-632. doi:10.35541/cjd.20200415

Lyu Sha, Wang Shuang, Wu Hanfei, Zhang Mingrui, Hu Xin, Li Fuqiu. Research progress in sporotrichosis[J]. Chinese Journal of Dermatology, 2022, 55(7): 629-632.doi:10.35541/cjd.20200415

参考文献 39

［1］	Hay R, Denning DW, Bonifaz A, et al. The diagnosis of fungal neglected tropical diseases （Fungal NTDs） and the role of investigation and laboratory tests: an expert consensus report［J］. Trop Med Infect Dis, 2019,4（4）:122. doi: 10.3390/tropicalmed 4040122.
［2］	Lopes⁃Bezerra LM, Mora⁃Montes HM, Zhang Y, et al. Sporotrichosis between 1898 and 2017: the evolution of knowledge on a changeable disease and on emerging etiological agents［J］. Med Mycol, 2018,56（suppl_1）:126⁃143. doi: 10.1093/ mmy/myx103.
［3］	Zhang Y, Hagen F, Stielow B, et al. Phylogeography and evolutionary patterns in Sporothrix spanning more than 14 000 human and animal case reports［J］. Persoonia, 2015,35:1⁃20. doi: 10.3767/003158515X687416.
［4］	Thomson J, Trott DJ, Malik R, et al. An atypical cause of sporotrichosis in a cat［J］. Med Mycol Case Rep, 2019,23:72⁃76. doi: 10.1016/j.mmcr.2019.01.004.
［5］	McGuinness SL, Boyd R, Kidd S, et al. Epidemiological investigation of an outbreak of cutaneous sporotrichosis, Northern Territory, Australia［J］. BMC Infect Dis, 2016,16:16. doi: 10.1186/s12879⁃016⁃1338⁃0.
［6］	Baptista VS, Mothé GB, Santos G, et al. Promising application of the SsCBF ELISA test to monitor the therapeutic response of feline sporotrichosis caused by Sporothrix brasiliensis from Brazilian epidemics［J］. Braz J Microbiol, 2020［2020⁃09⁃15］. doi: 10.1007/s42770⁃020⁃00362⁃6.［published online ahead of print 2020⁃08⁃18］
［7］	Kim JG, Kim HR, You MH, et al. Familial sporotrichosis due to human⁃to⁃human infection of sporothrix globosa: a case report［J］. J Mycol Infect, 2018,23（2）:54⁃58. doi: 10.17966/JMI.2018. 23.2.54.
［8］	Bahr NC, Janssen K, Billings J, et al. Respiratory failure due to possible donor⁃derived Sporothrix schenckii infection in a lung transplant recipient［J］. Case Rep Infect Dis, 2015,2015:925718. doi: 10.1155/2015/925718.
［9］	Govender NP, Maphanga TG, Zulu TG, et al. An outbreak of lymphocutaneous sporotrichosis among mine⁃workers in South Africa［J/OL］. PLoS Negl Trop Dis, 2015,9（9）:e0004096. doi: 10.1371/journal.pntd.0004096.
［10］	De Almeida AJ, Nahn Júnior EP, Vieira da Motta O, et al. Diagnosis of human sporotrichosis in Campos dos Goytacazes, Rio de Janeiro, Brazil［J］. J Infect Dev Ctries, 2019,13（8）:768⁃772. doi: 10.3855/jidc.11672.
［11］	Chakrabarti A, Bonifaz A, Gutierrez⁃Galhardo MC, et al. Global epidemiology of sporotrichosis［J］. Med Mycol, 2015,53（1）:3⁃14. doi: 10.1093/mmy/myu062.
［12］	Alzuguir C, Pereira SA, Magalhães M, et al. Geo⁃epidemiology and socioeconomic aspects of human sporotrichosis in the municipality of Duque de Caxias, Rio de Janeiro, Brazil, between 2007 and 2016［J］. Trans R Soc Trop Med Hyg, 2020,114（2）:99⁃106. doi: 10.1093/trstmh/trz081.
［13］	Yao L, Song Y, Cui Y, et al. Pediatric sporotrichosis in Jilin province of China （2010 - 2016）: a retrospective study of 704 cases［J］. J Pediatric Infect Dis Soc, 2020,9（3）:342⁃348. doi: 10.1093/jpids/piz052.
［14］	Mayorga⁃Rodríguez J, Leonardo Mayorga⁃Garibaldi J, Muñoz⁃Estrada VF, et al. Sporotrichosis: a 1 134 case serie of an endemic zone of Mexico［J］. Medicina Cutanea Ibero⁃Latino⁃Americana, 2019,47（1）:24⁃28.
［15］	Lv S, Wu HF, Wang B, et al. Sensitivities of periodic acid⁃Schiff staining, Grocott′s silver staining and calcofluor white staining in the diagnosis of human sporotrichosis［J］. Int J Clin Exp Pathol, 2019,12（9）:3459⁃3464.
［16］	Shao J, Song Y, Zhou Y, et al. Diagnostic value of fluorescein⁃labeled chitinase staining in formalin⁃fixed and paraffin⁃embedded tissues of fungal disease［J］. Med Mycol, 2020,58（1）:66⁃70. doi: 10.1093/mmy/myz035.
［17］	Bonifaz A, Toriello C, Araiza J, et al. Sporotrichin skin test for the diagnosis of sporotrichosis［J］. J Fungi （Basel）, 2018,4（2）doi: 10.3390/jof4020055.
［18］	Parreiras de Jesus AC, Grossi de Oliveira AL, Sernizon Guimarães N, et al. Serological tests using Sporothrix species antigens for the accurate diagnosis of sporotrichosis: a meta⁃analysis［J］. Diagn Microbiol Infect Dis, 2020,98（3）:115131. doi: 10.1016/j.diagmicrobio.2020.115131.
［19］	Zhang M, Li F, Gong J, et al. Development and evaluation of a real⁃time polymerase chain reaction for fast diagnosis of sporotrichosis caused by Sporothrix globosa［J］. Med Mycol, 2020,58（1）:61⁃65. doi: 10.1093/mmy/myz029.
［20］	Zhang M, Li F, Li R, et al. Fast diagnosis of sporotrichosis caused by Sporothrix globosa, Sporothrix schenckii, and Sporothrix brasiliensis based on multiplex real⁃time PCR［J/OL］. PLoS Negl Trop Dis, 2019,13（2）:e0007219. doi: 10.1371/journal. pntd.0007219.
［21］	Nami S, Aghebati⁃Maleki A, Morovati H, et al. Current antifungal drugs and immunotherapeutic approaches as promising strategies to treatment of fungal diseases［J］. Biomed Pharmacother, 2019,110:857⁃868. doi: 10.1016/j.biopha.2018. 12.009.
［22］	Batista⁃Duharte A, Lastre M, Romeu B, et al. Antifungal and immunomodulatory activity of a novel cochleate for amphotericin B delivery against Sporothrix schenckii［J］. Int Immunopharmacol, 2016,40:277⁃287. doi: 10.1016/j.intimp.2016.09.008.
［23］	Ferreira PG, Noronha L, Teixeira R, et al. Investigation of a microemulsion containing clotrimazole and itraconazole for transdermal delivery for the treatment of Sporotrichosis［J］. J Pharm Sci, 2020,109（2）:1026⁃1034. doi: 10.1016/j.xphs.2019. 10.009.
［24］	茹意, 顾云东, 郑淇, 等. 中医药治疗浅部真菌病循证医学60年回顾［J］. 中国真菌学杂志, 2018,13（2）:120⁃123.
［25］	Garcia Ferreira P, Pereira Borba⁃Santos L, Noronha LL, et al. Synthesis, stability studies, and antifungal evaluation of substituted α⁃ and β⁃2,3⁃dihydrofuranaphthoquinones against Sporothrix brasiliensis and Sporothrix schenckii［J］. Molecules, 2019,24（5）:930. doi: 10.3390/molecules24050930.
［26］	Poester VR, Mattei AS, Mendes JF, et al. Antifungal activity of diphenyl diselenide alone and in combination with itraconazole against Sporothrix brasiliensis［J］. Med Mycol, 2019,57（3）:328⁃331. doi: 10.1093/mmy/myy044.
［27］	Peter CM, Waller SB, Picoli T, et al. Chemical and cytotoxic analyses of three varieties of Brazilian propolis （green propolis, jataí propolis and brown propolis） and its anti⁃Sporothrix brasiliensis in vitro activity［J］. Arq bras med vet zootec, 2019,71（3）:819⁃827. doi: 10.1590/1678⁃4162⁃9918.
［28］	Villanueva⁃Lozano H, Treviño⁃Rangel RJ, Téllez⁃Marroquín R, et al. In vitro inhibitory activity of sertraline against clinical isolates of Sporothrix schenckii［J］. Rev Iberoam Micol, 2019,36（3）:139⁃141. doi: 10.1016/j.riam.2019.01.004.
［29］	Borba⁃Santos LP, Reis de Sá LF, Ramos JA, et al. Tacrolimus increases the effectiveness of itraconazole and fluconazole against Sporothrix spp［J］. Front Microbiol, 2017,8:1759. doi: 10.3389/fmicb.2017.01759.
［30］	López⁃Ramírez LA, Hernández NV, Lozoya⁃Pérez NE, et al. Functional characterization of the Sporothrix schenckii Ktr4 and Ktr5, mannosyltransferases involved in the N⁃linked glycosylation pathway［J］. Res Microbiol, 2018,169（3）:188⁃197. doi: 10.1016/j.resmic.2018.02.004.
［31］	Almeida⁃Paes R, Figueiredo⁃Carvalho MH, Brito⁃Santos F, et al. Melanins protect Sporothrix brasiliensis and Sporothrix schenckii from the antifungal effects of terbinafine［J/OL］. PLoS One, 2016,11（3）:e0152796. doi: 10.1371/journal.pone.0152796.
［32］	Nascimento RC, Almeida SR. Humoral immune response against soluble and fractionate antigens in experimental sporotrichosis［J］. FEMS Immunol Med Microbiol, 2005,43（2）:241⁃247. doi: 10.1016/j.femsim.2004.08.004.
［33］	de Almeida J, Jannuzzi GP, Kaihami GH, et al. An immunoproteomic approach revealing peptides from Sporothrix brasiliensis that induce a cellular immune response in subcutaneous sporotrichosis［J］. Sci Rep, 2018,8（1）:4192. doi: 10.1038/s41598⁃018⁃22709⁃8.
［34］	de Almeida JR, Santiago KL, Kaihami GH, et al. The efficacy of humanized antibody against the Sporothrix antigen, gp70, in promoting phagocytosis and reducing disease burden［J］. Front Microbiol, 2017,8:345. doi: 10.3389/fmicb.2017.00345.
［35］	Chen F, Jiang R, Wang Y, et al. Recombinant phage elicits protective immune response against systemic S. globosa infection in mouse model［J］. Sci Rep, 2017,7:42024. doi: 10.1038/srep42024.
［36］	Quinello C, Souza Ferreira L, Picolli I, et al. Sporothrix schenckii cell wall proteins⁃stimulated BMDCs are able to induce a Th1⁃Prone cytokine profile in vitro［J］. J Fungi （Basel）, 2018,4（3）:106. doi: 10.3390/jof4030106.
［37］	Portuondo DL, Batista⁃Duharte A, Ferreira LS, et al. Comparative efficacy and toxicity of two vaccine candidates against Sporothrix schenckii using either Montanide™ Pet Gel A or aluminum hydroxide adjuvants in mice［J］. Vaccine, 2017,35（34）:4430⁃4436. doi: 10.1016/j.vaccine.2017.05.046.
［38］	Portuondo DL, Dores⁃Silva PR, Ferreira LS, et al. Immunization with recombinant enolase of Sporothrix spp. （rSsEno） confers effective protection against sporotrichosis in mice［J］. Sci Rep, 2019,9（1）:17179. doi: 10.1038/s41598⁃019⁃53135⁃z.
［39］	Tso G, Reales⁃Calderon JA, Pavelka N. The elusive anti⁃candida vaccine: lessons from the past and opportunities for the future［J］. Front Immunol, 2018,9:897. doi: 10.3389/fimmu.2018.00897.

[1]	王媛李志量李锁荆可孙超梁桂熔张寒梅冯素英. 抗p200类天疱疮7例临床及免疫血清学特征分析[J]. 中华皮肤科杂志, 2022, 55(7): 557-561.
[2]	曾凡荣沈云良杜娜吴李梅费丽娟王燕敏. 浙江省2011—2020年生殖器疱疹流行特征与趋势分析[J]. 中华皮肤科杂志, 2022, 55(7): 571-575.
[3]	高子蕊赵培窦沅青刘萍张建中. 度普利尤单抗治疗成人结节性痒疹的疗效与安全性观察[J]. 中华皮肤科杂志, 2022, 55(7): 562-565.
[4]	王玲艳潘靖苗钢常晓丹金秋子郭宁宁张佳钰. 对生物制剂治疗抵抗的银屑病患者皮损部位分析[J]. 中华皮肤科杂志, 2022, 55(7): 583-587.
[5]	张宁李舒李敬. 免疫检查点抑制剂和靶向药物辅助治疗可切除黑素瘤疗效的网状Meta分析[J]. 中华皮肤科杂志, 2022, 55(7): 603-609.
[6]	温广东冒丹丹张原媛窦沅青赵培吴晨雨张建中. 【开放获取】度普利尤单抗治疗泛发性苔藓状淀粉样变1例国内首报[J]. 中华皮肤科杂志, 2022, 55(6): 508-510.
[7]	中华医学会皮肤性病学分会特应性皮炎研究中心中华医学会皮肤性病学分会儿童学组. 【开放获取】度普利尤单抗治疗特应性皮炎专家共识[J]. 中华皮肤科杂志, 2022, 55(6): 465-470.
[8]	赵柳琦陈妍陈丹阳樊碧娆王瑞尚盼盼陈喜雪朱学骏王明悦. 【开放获取】度普利尤单抗治疗大疱性类天疱疮21例的疗效及安全性回顾分析[J]. 中华皮肤科杂志, 2022, 55(6): 480-485.
[9]	黄馨陈筱昀李亚萍梁兴堃张桂英周英湛意罗帅寒天廖洁月肖嵘龙海. 度普利尤单抗治疗123例特应性皮炎的疗效及安全性分析[J]. 中华皮肤科杂志, 2022, 55(6): 486-493.
[10]	张晓陈凤鸣柳琳罗莉郭金高天文石琼. Ⅰ期皮肤黑素瘤163例临床病理特征及预后分析[J]. 中华皮肤科杂志, 2022, 55(5): 389-394.
[11]	申晨陶娟. 特应性皮炎长期控制的评估演变与达标治疗[J]. 中华皮肤科杂志, 2022, 55(5): 442-445.
[12]	胡烨蓓宋秀祖. 氨甲环酸治疗黄褐斑的研究进展[J]. 中华皮肤科杂志, 2022, 55(5): 460-462.
[13]	罗帅寒天龙海陆前进, . 2021年系统性红斑狼疮研究新进展[J]. 中华皮肤科杂志, 2022, 55(4): 369-372.
[14]	李巍尹慧彬. 特应性皮炎的部位异质性[J]. 中华皮肤科杂志, 2022, 55(4): 349-352.
[15]	李妍李明徐薇李邻峰. 【开放获取】凯普斯泰冷敷凝胶治疗成人轻中度特应性皮炎的随机双盲对照研究[J]. 中华皮肤科杂志, 2022, 55(4): 345-348.

孢子丝菌病研究进展

Research progress in sporotrichosis

PDF

PDF (Mobile)

可视化

摘要/Abstract

引用本文

使用本文

参考文献 39

相关文章 15

Metrics

本文评价

推荐阅读 10